The Combination of Terbutaline and Danazol as the Treatment of Corticosteroid-resistant/Relapse Immune Thrombocytopenia
Clinical trial NCT05494307 · UNKNOWN
Trial details
- NCT number
- NCT05494307
- Sponsor
- Peking University People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-01
- Primary completion
- 2023-09-01
- Enrollment
- 228
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.